AiThority Interview With Michael Power, CEO, VieCure

Michael Power, CEO, VieCure comments on the many ways in which AI is enabling better precision based medical care and treatments in this AiThority.com interview:

_______

Hi Michael, tell us about VieCure, the journey so far and the highlights around your latest funding? 

VieCure was founded to solve a critical industry need: community oncologists, who care for the majority of cancer patients, were being asked to deliver precision medicine without the operating systems or real‑time insights needed to do so.

Fragmented clinical information, rapidly evolving guidelines, new treatment availability, and increasingly complex genomic data created barriers that prevented patients from receiving the most effective therapies at the right moment. VieCure’s Halo Intelligence™ platform was designed to close that gap by unifying clinical, genomic, and patient‑reported data into a single intelligent ecosystem that guides oncologists through truly personalized care.

This mission became even more personal when my mother, Margaret Power, was diagnosed with stage IV lung cancer. Because she was properly staged, sequenced, and supported through our platform, she received a precision‑guided treatment plan that allowed her to live a longer, active life. To me, this was proof of what can happen when the right technology is placed in the hands of the clinicians who need it most. Her experience reaffirmed why we built VieCure: to bring the power of precision oncology to every community, not just academic centers.

We are committed to translating our founding purpose into real‑world impact. Halo Intelligence™ is the operating system community cancer centers have chosen for care delivery, serving nearly 30,000 patients, and is driving measurable improvements in sequencing rates and guideline‑concordant care. Our recent $43M funding round enables us to accelerate that momentum, expanding our AI capabilities, enhancing clinical content, and growing our national network of community oncologists. For us, the true highlight of this journey is simple: seeing precision oncology become a reality for patients everywhere.

Tell us more about the benefits of AI-powered platforms in medical care and Oncology and how this is growing in importance?

AI can convert complex, fragmented clinical data into timely, evidence-based guidance at the point of care. As modern cancer care grows more complex, it is important that AI decision-making tools are available to oncologists everywhere, particularly for the 80% of cancer patients who receive treatment in community-based practices. VieCure’s digital ecosystem combines this AI-powered real-time clinical support with purpose-built oncology EMR, a suite of applications, and workflow tools to help community oncologists determine the right treatment path for every patient. 

Also Read: AiThority Interview With Arun Subramaniyan, Founder & CEO, Articul8 AI

How are modern healthcare organizations / hospitals opening up to data driven precision based care? What are some of the top challenges they face when it comes to adopting / implementing these systems? 

Modern healthcare organizations increasingly recognize that delivering high‑quality cancer care requires keeping pace with rapid scientific and technological advancements. Yet many systems are still constrained by outdated technologies, manual workflows, and siloed data, making it difficult to operationalize precision medicine at scale.

Community oncologists specifically often face limited resources, heavy patient loads, shifting payer requirements, and are tasked to navigate constantly evolving clinical standards. These pressures can strain both clinical operations and financial sustainability often creating new barriers, to adopt new diagnostics and therapeutics or maintain guideline‑aligned care.

This is exactly where data‑driven precision platforms create meaningful impact. By integrating disparate data sources and translating clinical complexity into real‑time, actionable treatment guidance, these systems empower oncologists to deliver more personalized, meaningful patient care (without adding operational burden). With the proper systems in place, organizations are also better equipped to improve patient outcomes, streamline workflows, and remain sustainable in an increasingly demanding and evolving ecosystem.

Also read: Artificial Intelligence (AI) and The Future of Medical Care 

What AI and technology trends will define healthcare through 2026 and beyond?

AI and advanced analytics will increasingly become the backbone of modern healthcare, especially as cancer care grows more complex and data‑intensive. By 2026, AI‑powered platforms will shift from a suite of built-on applications to a core clinical operating system that supports clinicians with the workflows they need to deliver frictionless care.

Looking ahead, AI will not just accelerate decision‑making; it will help standardize care quality across diverse practice environments. The organizations that thrive will be those that adopt platforms capable of continuous learning, adaptation to new evidence, and delivery of point‑of‑care insights that keep pace with the rapid evolution of precision medicine. 

Can you highlight more about some of the leading healthcare facilities from around the world and how they’ve been using AI powered precision care to enable better cancer care outcomes?

Across the U.S., we’re already seeing healthcare facilities adopt AI‑powered precision tools to improve everything from daily operations to complex clinical decision‑making. Many centers now rely on AI for routine but mission‑critical tasks, scheduling, triage, diagnostic coordination, and care navigation. This level of insight is essential to ensure patients can access timely evaluations and treatments without bottlenecks.

We’re also seeing more advanced use cases emerge, where AI helps synthesize clinical, genomic, and population‑level data to predict cancer risk, identify the most effective therapies earlier, and guide oncologists toward personalized treatment paths. These capabilities are especially powerful in community settings, where clinicians need real-time support to keep pace with rapidly evolving science.

Looking ahead, AI will become foundational to the operating systems that power cancer care. Even as these tools advance, one truth remains: healthcare is ultimately human. The most meaningful progress will come from providers, patients, and innovators working together to deliver care that is both technologically advanced and deeply compassionate.

[To share your insights with us, please write to psen@itechseries.com